Tumor Necrosis Factor-α Promoter Gene Polymorphisms Are Not Associated with Hepatitis C Virus Infection in Chinese Hemodialysis Patients

REFERENCES

• Fabrizi F, Messa P, Martin P. Impact of hemodialysis therapy on hepatitis C virus infection: A deeper insight. Int J Artif Organs. 2009;32:1–11.
   PubMed Web of Science ®Google Scholar
• Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial. 2005;18:52–61.
   PubMed Web of Science ®Google Scholar
• Sun J, Yu R, Zhu B, Wu J, Larsen S, Zhao W. Hepatitis C infection and related factors in hemodialysis patients in China: Systematic review and meta-analysis. Ren Fail. 2009;31:610–620.
   PubMed Web of Science ®Google Scholar
• Soto-Salgado M, Perez CM, Burgos-Calderon R, Torres EA, Suarez E. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005. P R Health Sci J. 2009;28:18–23.
   PubMedGoogle Scholar
• Stojanovic M, Stojanovic D, Stefanovic V. The impact of malnutrition on mortality in patients on maintenance hemodialysis in Serbia. Artif Organs. 2008;32:398–405.
   PubMedGoogle Scholar
• Di Napoli A, Pezzotti P, Di Lallo D, . Epidemiology of hepatitis C virus among long-term dialysis patients: A 9-year study in an Italian region. Am J Kidney Dis. 2006;48:629–637.
   PubMed Web of Science ®Google Scholar
• Machida K, Tsukamoto H, Liu JC, . c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair. Hepatology. 2010;52:480–492.
   PubMed Web of Science ®Google Scholar
• Levrero M. Viral hepatitis and liver cancer: The case of hepatitis C. Oncogene. 2006;25:3834–3847.
   PubMed Web of Science ®Google Scholar
• Thomas DL, Thio CL, Martin MP, . Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461:798–801.
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Borrow P, Hobbs MV, . Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci USA. 1996;93:4589–4594.
   PubMedGoogle Scholar
• McCarthy JJ, Li JH, Thompson A, . Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology. 2010;138:2307–2314.
   PubMed Web of Science ®Google Scholar
• Kanzler S, Baumann M, Schirmacher P, . Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-β. J Viral Hepat. 2001;8:430–437.
   PubMed Web of Science ®Google Scholar
• Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94:3195–3199.
   PubMed Web of Science ®Google Scholar
• Baseggio L, Bienvenu J, Charlot C, . High LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin’s lymphoma patients. Exp Hematol. 2001;29:330–338.
   PubMedGoogle Scholar
• Chen TY, Hsieh YS, Wu TT, . Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Transl Res. 2007;150:116–121.
   PubMed Web of Science ®Google Scholar
• Thio CL, Goedert JJ, Mosbruger T, . An analysis of tumor necrosis factor α gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection. Genes Immun. 2004;5:294–300.
   Google Scholar
• Kusumoto K, Uto H, Hayashi K, . Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine. 2006;34:24–31.
   PubMedGoogle Scholar
• Singhal S, Kohaar I, Bharadwaj M, Shukla DK, Das BC, Kar P. Association of tumor necrosis factor-alpha gene promoter polymorphisms with acute viral hepatitis in the Indian population. Dig Dis Sci. 2010;55:1106–1112.
   PubMedGoogle Scholar
• Sheu JC, Lee SH, Wang JT, Shih LN, Wang TH, Chen DS. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. J Med Virol. 1992;37:108–112.
   PubMed Web of Science ®Google Scholar
• Lin DY, Lin HH, Hunan CC, Liaw YF. High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis. 1993;21:288–291.
   PubMedGoogle Scholar
• Taniuchi S, Masuda M, Teraguchi M, . Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease. J Clin Immunol. 2005;25:309–313.
   PubMed Web of Science ®Google Scholar
• van Belzen MJ, Mulder CJ, Zhernakova A, Pearson PL, Houwen RH, Wijmenga C. CTLA4 +49 A/G and CT60 polymorphisms in Dutch coeliac disease patients. Eur J Hum Genet. 2004;12:782–785.
   PubMed Web of Science ®Google Scholar
• Al-Jamal M, Al-Qudah A, Al-Shishi KF, Al-Sarayreh A, Al-Quraan L. Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan. Saudi J Kidney Dis Transpl. 2009;20:488–492.
   PubMedGoogle Scholar
• Nicolardi E, Grieco A, Rapaccini GL, Pompili M. Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients. G Ital Nefrol. 2010;27(3):262–273.
   PubMedGoogle Scholar
• Takaki A, Wiese M, Maertens G, . Cellular immune response persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000;6:578–582.
   PubMed Web of Science ®Google Scholar
• Dai CY, Chuang WL, Lee LP, . Associations of tumor necrosis factor alpha promoter polymorphisms at position −308 and −238 with clinical characteristics of chronic hepatitis C. J Viral Hepat. 2006;13:770–774.
   PubMed Web of Science ®Google Scholar
• Hohler T, Kruger A, Gerken G, . Tumor necrosis factor alpha promoter polymorphism at position −238 is associated with chronic active hepatitis C infection. J Med Virol. 1998;54:173–177.
   PubMedGoogle Scholar
• Souza JF, Longui CA, Miorin LA, Sens YA. Gamma-glutamyltransferase activity in chronic dialysis patients and renal transplant recipients with hepatitis C virus infection. Transplant Proc. 2008;40:1319–1323.
   PubMedGoogle Scholar
• Lampe E, Yoshida CF, De Oliveira RV, Lauer GM, Lewis-Ximenez LL. Molecular analysis and patterns of ALT and hepatitis C virus seroconversion in hemodialysis patients with acute hepatitis. Nephrology. 2008;13:186–192.
   PubMed Web of Science ®Google Scholar
• Abbas Z, Moatter T, Hussainy A, Jafri W. Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3. World J Gastroenterol. 2005;11:6656–6661.
   PubMedGoogle Scholar
• Barrett S, Collins M, Kenny C, Ryan E, Keane CO, Crowe J. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol. 2003;71:212–218.
   PubMed Web of Science ®Google Scholar
• Martín J, de Sequera P, Quiroga JA, . Role of hemodialysis and hepatitis C virus infection in spontaneous and induced cytokine production of patients with chronic renal disease. Cytokine. 2000;12:1248–1252.
   PubMedGoogle Scholar
• Spanakis NE, Garinis GA, Alexopoulos EC, . Cytokine serum levels in patients with chronic HCV infection. J Clin Lab Anal. 2002;16:40–46.
   PubMedGoogle Scholar